News

U.S. Supreme Court mifepristone case could make abortions even harder to access in Kansas City The Beacon | By Suzanne King Published March 27, 2024 at 4:00 AM CDT ...
If mifepristone’s federal approval were rescinded, ... How will that affect KS and MO? March 25, ... 913-735-3689 Jonathan Shorman is The Kansas City Star’s lead political reporter, ...
Two Missouri men already facing charges in the mysterious case of three friends found dead outside a Kansas City home after ...
FILE – A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022.
Abortion providers in three states filed a lawsuit Monday aimed at preserving access to the abortion pill mifepristone. Skip to content. NOWCAST KMBC 9 News at 5PM Sunday.
A Kansas abortion clinic is suing the Food and Drug Administration over access to telemedicine abortion pill mifepristone. Trust Women, an abortion clinic in Wichita, joined providers from Montana ...
photo by: Charlie Riedel/AP A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kansas, on, Oct. 12, 2022.
Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an earli… ...
Missouri, Kansas and Idaho have renewed their efforts to restrict access to the abortion drug mifepristone, filing a joint amended lawsuit against the Food and Drug Administration (FDA).
KANSAS CITY - The Trump administration has asked a judge to toss out a lawsuit from three Republican-led states seeking to cut off telehealth access to the abortion medication mifepristone ...
Attorney: ICE detains Kansas City mother. The mother is a single parent with three kids at home, including a 5-year-old with severe autism.
Missouri, Kansas, and Idaho renewed their challenge to the FDA's approval of abortion drug mifepristone, seeking to restrict access and ban its use earlier in a pregnancy.